It will be important in the future to characterize the whole transcriptome under YAP/TAZ modulation in addition to microRNAs because competing endogenous RNAs, long noncoding RNAs, and enhancer-associated RNAs are emerging for their role in development and cancer, including lung cancer [177,178]). The gene discussed is YAP1; the disease is lung carcinoma.